A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

Bilingualism has long been known to have cognitive benefits for older adults. Research shows it helps delay the onset of ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...

Politicians, like everyone else, age. Some will develop Alzheimer's disease or dementia. How worried should we be about ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...